Last reviewed · How we verify
Paracetamol hot drink
Paracetamol acts as an inhibitor of COX-2 enzyme.
Paracetamol acts as an inhibitor of COX-2 enzyme. Used for Pain relief, Fever reduction.
At a glance
| Generic name | Paracetamol hot drink |
|---|---|
| Sponsor | GlaxoSmithKline |
| Drug class | Non-opioid analgesic |
| Target | COX-2 |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 2 |
Mechanism of action
This inhibition leads to a decrease in the production of prostaglandins, which are responsible for pain and fever.
Approved indications
- Pain relief
- Fever reduction
Common side effects
- Nausea
- Vomiting
- Abdominal pain
Key clinical trials
- To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers (PHASE1)
- A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis (PHASE3)
- Effect of Paracetamol on the Common Cold (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Paracetamol hot drink CI brief — competitive landscape report
- Paracetamol hot drink updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI